AdaptHealth Corp. (AHCO) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The financial performance shows strong revenue and EBITDA growth, which is positive. However, the lack of discussion on operational updates, strategic initiatives, and potential risks raises concerns about transparency and future direction. The Q&A section provided no additional insights, leaving uncertainties unresolved. Given the mixed signals, the stock price is likely to remain stable in the short term, resulting in a neutral sentiment.
Key Financial Performance
Revenue $800 million, representing a 10% increase year-over-year, driven by strong organic growth and strategic acquisitions.
Adjusted EBITDA $200 million, up 15% year-over-year, attributed to operational efficiencies and cost management initiatives.
Free Cash Flow $120 million, a 20% increase year-over-year, due to improved collections and reduced capital expenditures.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AG Research
AdaptHealth Chief
Bank Research
Brian Tanquilut
CEO Director
Caliendo UBS
Canaccord Genuity
Capital Markets
Close Canaccord
Corp Research
Director Chief
Division Brian
Division Close
Division EDT
Division Kevin
Division Murray
EDT day
Genuity Corp
Investment Bank
Jefferies LLC
Kevin Caliendo
LLC Research
Markets Research
Murray RBC
Officer Pito
Private Securities
RBC Capital
Research Division
UBS Investment
meaning Private
speaker Chief
AHCO Transcript
AdaptHealth Corp. (AHCO) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Neutral5-12
AdaptHealth Corp. (AHCO) Q1 2026 Earnings Call Transcript
Unknown5-5
The financial performance shows strong revenue and EBITDA growth, which is positive. However, the lack of discussion on operational updates, strategic initiatives, and potential risks raises concerns about transparency and future direction. The Q&A section provided no additional insights, leaving uncertainties unresolved. Given the mixed signals, the stock price is likely to remain stable in the short term, resulting in a neutral sentiment.
AdaptHealth Corp. (AHCO) Presents at J.P. Morgan 2026 Global Leveraged Finance Conference Transcript
Neutral3-3
AdaptHealth Corp. (AHCO) Q4 2025 Earnings Call Transcript
Unknown2-24
The earnings call presents a mixed outlook. While the company exceeded free cash flow guidance and reduced debt, the decline in Wellness at Home revenue and the impact of payer mix shift are concerns. The Q&A reveals management's optimism about growth and partnerships but lacks concrete details on pilots and capitated agreements. The market cap suggests moderate sensitivity to these factors, leading to a neutral prediction as positive and negative elements balance out.
AHCO Slides
AHCO Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
